Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BioLink-2018 by Protheragen for Unspecified B-Cell Lymphomas: Likelihood of Approval
BioLink-2018 is under clinical development by Protheragen and currently in Phase I for Unspecified B-Cell Lymphomas. According to GlobalData, Phase...